OmniComm Systems to be Acquired by Anju Software

Article

Applied Clinical Trials

OmniComm Systems, Inc. has announced that it has entered into a merger agreement with Anju Software, Inc., under which OmniComm will become a wholly owned subsidiary of Anju. The closing is expected to occur by October 31, 2019 following the satisfaction of customary closing conditions.  

Find more details of the aquisition, right here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
Related Content
© 2024 MJH Life Sciences

All rights reserved.